Table 1 Analysis of baseline characteristics
Control group | Neostigmine groups | |||||
|---|---|---|---|---|---|---|
NS (n = 47) | 20 µg/kg (n = 49) | 40 µg/kg (n = 50) | 50 µg/kg (n = 50) | H or X2 | P | |
Age (y) | 67 (64,70) | 68 (65,71) | 68 (63,71) | 68 (66,73) | 2.900 | 0.402 |
Gender | 3.450(X2) | 0.327 | ||||
Male (%) | 20 (42.6%) | 23 (46.9%) | 22 (44.0%) | 15 (30.0%) | ||
Female (%) | 27 (57.4%) | 26 (53.1%) | 28 (56.0%) | 35 (70.0%) | ||
BMI (kg/m2) | 23.1 (21.1,24.3) | 23.15 (21.3, 25.4) | 22.5 (20.0, 24.6) | 22.4 (19.2, 24.8) | 2.900 | 0.409 |
duration of surgery (min) | 185 (140,258) | 187.5 (148.75,306.5) | 200 (156,265) | 190 (133,247) | 2.410 | 0.492 |
duration of anesthesia (min) | 200 (155,300) | 213.5 (174.5,322.5) | 225 (175,290) | 205 (153,280) | 2.535 | 0.469 |
Cisatracurium (mg) | 23 (18,30) | 20 (14,30) | 24 (16.5,38) | 24 (16,30) | 3.040 | 0.385 |
blood loss (ml) | 100 (50,200) | 100 (50,337.5) | 200 (50,425) | 200 (50,500) | 9.776 | 0.021 |
fluid infusion (ml) | 2100 (1600, 3400) | 2600 (2100,3137.5) | 2600 (2050,3150) | 2550 (1600,3250) | 5.579 | 0.134 |
T＜36.0℃ (n) | 0 | 3 | 3 | 4 | ||
Type of surgery (%) | 12.199(X2) | 0.379 | ||||
Gynecology | 9 (19.1%) | 9 (18.4%) | 9 (18.0%) | 10 (20.0%) | ||
orthopedics | 6 (12.8%) | 11 (22.4%) | 15 (30.0%) | 17 (34.0%) | ||
Urology | 7 (14.9%) | 7 (14.3%) | 6 (12.0%) | 5 (10.0%) | ||
General Surgery | 22 (46.8%) | 22 (44.9%) | 20 (40.0%) | 18 (36.0%) | ||
Thoracic Surgery | 3 (6.4%) | 0 | 0 | 0 | ||